Lager Joanne Jenkins 4
4 · iTeos Therapeutics, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Lager Joanne Jenkins
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-03$4.30/sh+7,000$30,100→ 7,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-03−7,000→ 189,438 totalExercise: $4.30Exp: 2025-06-11→ Common Stock (7,000 underlying) - Sale
Common Stock
2022-01-03$51.90/sh−7,000$363,300→ 0 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2021.
- [F2]One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date